Byotrol
Chris Sedwell is an experienced finance professional currently serving as Managing Director and Chief Financial Officer at Byotrol since December 2021. Prior to this, Chris held the position of Portfolio Finance Director/CFO at The FD & CFO Centre UK, providing part-time Finance Director services to businesses in the North West of England and Wales. Chris's extensive background includes leadership roles at ConvaTec, Iceland Foods, McInerney Homes, Redrow Homes, Unilever, and Deloitte, where a strong focus on financial management, operational finance, and audit services has been demonstrated. Chris holds a Master of Philosophy and a Bachelor of Arts in Music from the University of Liverpool.
This person is not in any teams
Byotrol
Byotrol provides specialist biosecurity and infection control solutions, designed to protect people and animals from disease. Our unique products are grounded in excellent science; developed by our team of hygiene experts, and supported by robust data that our customers trust. We promote safe, effective and sustainable biosecurity and infection control measures, which improve the health of people, animals and the environment. Byotrol’s first antimicrobial technology was invented and patented in the 1990s, with the goal of creating an antimicrobial coating to prevent mould in a bakery. That first product proved to be highly effective, fast-acting, and broad-spectrum, but in addition had unique long-lasting germ-kill properties, continuing to work long after it had dried. The original Byotrol technology has been used in millions of businesses and homes around the world, helping to prevent infection in hospitals, controlling Listeria in food factories, and cleaning and protecting our homes and families from harmful pathogens. Byotrol's portfolio of technologies and products has grown extensively under our own brands and with carefully selected partners in a variety of applications and markets. Byotrol’s products are now sold and used throughout Europe, North America, South Africa, and Asia. We have invested heavily in scientific excellence, with our team of scientists, product development, and regulatory specialists now operating out of outstanding laboratories in the North-West of England, at Thornton Science Park, University of Chester campus. Byotrol’s ongoing innovation programme ensures we remain at the forefront of the industry, with a focussed pipeline of research and development to discover new and disruptive biocidal technologies, as well as a number of joint development agreements in partnership with key customers.